Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study. Scaldaferri F, Di Vincenzo F, Aloi M, Ascolani M, et al. Am J Gastroenterol 2026 Feb 18. doi: 10.14309/ajg.0000000000003969.

Read + Share

Amedeo Smart

Independent Medical Education

Scaldaferri F, Di Vincenzo F, Aloi M, Ascolani M, et al. Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study. Am J Gastroenterol 2026 Feb 18. doi: 10.14309/ajg.0000000000003969.
PMID: 41705712